newmigrainestudy.com Open in urlscan Pro
209.17.116.160  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Toggle navigation
   
 * 
 * THE RELIEV-CM2 STUDY
 * WHY PARTICIPATE?




ARE YOU LIVING WITH
FREQUENT MIGRAINE?


LOCAL DOCTORS ARE STUDYING A NON-DRUG TREATMENT
FOR MIGRAINE SUFFERERS EXPERIENCING 15 OR MORE
HEADACHE DAYS A MONTH.

Living with migraine is about more than enduring the symptoms. It makes engaging
in daily activities challenging. For some, migraine frequency increases leading
to chronic attacks.

Chronic Migraine:

 * 15+ headache days per month
 * Episodes lasting more than 4 hours

For many people, migraine medications and treatments do not provide adequate
relief of migraine frequency and/or severity.

If you are living with frequent migraine and have not received long-term relief
from other treatments, you may qualify for the RELIEV-CM2 Clinical Study. The
study is evaluating the ShiraTronics System, a small device placed under your
skin that delivers mild electrical pulses to nerves associated with migraine
pain. Participants in the RELIEV-CM2 Study will receive the ShiraTronics System
and all study-related care at no cost.

ABOUT THE STUDY

The RELIEV-CM2 Study for Migraine

Doctors at select centers in the United States and Australia are conducting the
RELIEV-CM2 Study. The study is evaluating the ShiraTronics System, a small
device that is designed to deliver mild electrical pulses to target migraine
signals.

What is neuromodulation?
Neuromodulation is a non-drug treatment for chronic pain that uses a small
device implanted under your skin called a neurostimulator. The neurostimulator
delivers mild electrical pulses to nerves associated with migraine pain around
the back and front of your head. These electrical pulses interrupt or change the
transmission of pain signals to the brain, which can potentially relieve your
chronic migraine pain. Neuromodulation therapy has been used for decades to
treat various chronic pain conditions.

How does it work?
You can 'test drive' neuromodulation therapy for about a week before deciding on
a permanent system. Your doctor will place the temporary system by threading
thin wires, called leads, along the nerve pathways involved with migraine
symptoms. The leads connect to an external temporary device that delivers gentle
pulses for the duration of the ‘test drive.’ After one week, the temporary
system is removed. You and your doctor can discuss whether this therapy is right
for you long-term. If you choose to have the permanent device placed under your
skin, this will be done through a short, reversible procedure a few weeks later.

SEE IF YOU QUALIFY

Why Participate?

If you are living with frequent migraine and have not received relief from other
treatments, you may qualify for the RELIEV-CM2 Clinical Study. The study is
evaluating the ShiraTronics System, a small device that works under your skin
and is designed to target migraine signals.

If you qualify and choose to join the study, you may receive:

 * Evaluation of your migraine condition by a local physician specialist
 * The ShiraTronics System and study-related care at no cost
 * Compensation for your time and travel to attend follow-up visits at your
   study doctor’s office
 * The opportunity to help advance a new medical device technology to
   potentially benefit others suffering from migraine

SEE IF YOU QUALIFY

See If You Qualify

To see if you might qualify for the RELIEV-CM2 Study, and to get connected with
your local study center, please take the questionnaire below:

--------------------------------------------------------------------------------





 *